NEW YORK, Dec 19 – Motorola said Tuesday it had reached an agreement to exclusively license Molecular Staging’s Rolling Circle Amplification Technology for use in its diagnostic nucleic acid bioarrays, marking Motorola’s fourth genomics collaboration as it attempts to gain a foothold in the burgeoning market.

In exchange for the technology, Motorola will pay a licensing fee as well as make equity investments in Molecular Staging. Motorola also received an option to increase its stake in the future.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.